Needle Stick InjuriesNCT07055100
Determination of NSI Regarding Bloodborne Pathogens Among Healthcare Workers at Tertiary Care, DIK
An observational study of Needle Stick Injuries, run by Superior University at 1 site in Pakistan.
Trial summary
Bloodborne pathogens (BBPs) are a significant occupational hazard for healthcare professionals, particularly those working in high-risk environments like emergency departments. This study aims to assess the prevalence of bloodborne pathogens, including Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human… Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Needle Stick Injuries
- What is being tested?
- Needle stick injuries
- How many people
- 280 participants
- Where
- 1 sitePakistan
- Study dates
- 17 Mar 2025to 28 Feb 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Study population: A descriptive cross-sectional study design will be employed, and data will be collected from all staff working in the trauma center through census sampling. A structured questionnaire will capture demographic data, occupational risk factors, and KAP regarding bloodborne pathogens. Blood samples will be collected to screen for HBV, HCV, and HIV infections.
Who may be able to join
- Healthcare workers (doctors, nurses, technologists, paramedics, and support staff) working in a tertiary care hospital in Dera Ismail Khan.
- Staff members who have occupational exposure to blood and other body fluids.
- Individuals willing to participate in the study and provide informed consent.
- Participants available during the data collection period and conveniently accessible.
Who cannot join
- Individuals not willing to participate in the study and provide informed consent.
- Participants and Staff members who have no exposure to blood and other body fluids.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Determination of Needle Stick Injury Regarding Bloodborne Pathogens Among Healthcare Workers at Tertiary Care Hospital Dera Ismail Khan
Bloodborne pathogens (BBPs) are a significant occupational hazard for healthcare professionals, particularly those working in high-risk environments like emergency departments. This study aims to assess the prevalence of bloodborne pathogens, including Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human Immunodeficiency Virus (HIV), among emergency department staff of District Head Quarter (DHQ) Hospital, Dera Ismail Khan.
Read the detailed description
A descriptive cross-sectional study design will be employed, and data will be collected from all staff working in the trauma center through census sampling. A structured questionnaire will capture demographic data, occupational risk factors, and KAP regarding bloodborne pathogens. Blood samples will be collected to screen for HBV, HCV, and HIV infections.
- Conditions
- Needle Stick Injuries
- Being tested
- Needle stick injuries
- Medical subject headings
- Needlestick Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Needle stick injuriesDiagnostic test
A descriptive cross-sectional study design will be employed, and data will be collected from all staff working in the trauma center through census sampling. A structured questionnaire will capture demographic data, occupational risk factors, and KAP regarding bloodborne pathogens. Blood samples will be collected to screen for HBV, HCV, and HIV infections.
What is being measured
The primary outcome is the main question the study is designed to answer.
self administered questioner for NSI
The following data is collected for NSI, the value ranges from 0- 50, the higher the value is worse and lower value is good
Measured: 12 Months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jul 2025
- Study start17 Mar 2025
- Primary completion1 Sep 2025 (estimated)
- Study completion28 Feb 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Needle Stick InjuriesStudies of the same condition, open and under way.
- More trials run by Superior UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Retrospective
- Enrolment
- 280 participants (actual)
Sponsor and investigators
- Lead sponsor
- Superior University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Muhammad Naveed Babur, Superior University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07055100
- Sponsor's protocol ID
- MSAHSW/Batch-Fall23/919
- Status last verified
- Jul 2025
- First submitted
- 26 Jun 2025
- Last updated
- 8 Jul 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Determination of Needle Stick Injury Regarding Bloodborne Pathogens Among Healthcare Workers at Tertiary Care Hospital Dera Ismail Khan
- ClinicalTrials.gov ID
- NCT07055100
- Acronym / sponsor ID
- MSAHSW/Batch-Fall23/919
- Conditions
- Needle Stick Injuries
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 280 participants (actual)
- Lead sponsor
- Superior UniversityUniversity, hospital or other
- Study start
- 17 Mar 2025 (actual)
- Primary completion
- 1 Sep 2025 (estimated)
- Study completion
- 28 Feb 2026 (estimated)
- First posted
- 8 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Bloodborne pathogens (BBPs) are a significant occupational hazard for healthcare professionals, particularly those working in high-risk environments like emergency departments. This study aims to assess the prevalence of bloodborne pathogens, including Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human Immunodeficiency Virus (HIV), among emergency department staff of District Head Quarter (DHQ) Hospital, Dera Ismail Khan.
Detailed description
A descriptive cross-sectional study design will be employed, and data will be collected from all staff working in the trauma center through census sampling. A structured questionnaire will capture demographic data, occupational risk factors, and KAP regarding bloodborne pathogens. Blood samples will be collected to screen for HBV, HCV, and HIV infections.
Study design
- Observational model
- Case-control
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- A descriptive cross-sectional study design will be employed, and data will be collected from all staff working in the trauma center through census sampling. A structured questionnaire will capture demographic data, occupational risk factors, and KAP regarding bloodborne pathogens. Blood samples will be collected to screen for HBV, HCV, and HIV infections.
Key inclusion criteria (4 listed)
- Healthcare workers (doctors, nurses, technologists, paramedics, and support staff) working in a tertiary care hospital in Dera Ismail Khan.
- Staff members who have occupational exposure to blood and other body fluids.
- Individuals willing to participate in the study and provide informed consent.
- Participants available during the data collection period and conveniently accessible.
Key exclusion criteria (2 listed)
- Individuals not willing to participate in the study and provide informed consent.
- Participants and Staff members who have no exposure to blood and other body fluids.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Needle stick injuriesA descriptive cross-sectional study design will be employed, and data will be collected from all staff working in the trauma center through census sampling. A structured questionnaire will capture demographic data, occupational risk factors, and KAP regarding bloodborne pathogens. Blood samples will be collected to screen for HBV, HCV, and HIV infections. | Diagnostic test | – |
Primary outcome
self administered questioner for NSI
Time frame: 12 Months
The following data is collected for NSI, the value ranges from 0- 50, the higher the value is worse and lower value is good
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jul 2025.
- Individual participant dataSharing planned: No
Related trials for Needle Stick Injuries
Enrolling by invitationObservational study
A Study of VAX-ID® 2200, a New Device for Intradermal Injections
Sharps Injuries
Recruiting
ShotBlocker During Intramuscular Injection Randomized Control Trial
Neonatal Pain
Not yet recruiting
AI-Supported Gamified Training for Sharps Injury Prevention in Nurses
Sharps Injuries, Needlestick Injuries
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Needle Stick Injuries, run by Superior University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 8 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
self administered questioner for NSI (time frame: 12 Months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2025.